ID   FRTL-5 H-RAS(V12) clone V27
AC   CVCL_E5TX
SY   V27
RX   PubMed=15388794;
RX   PubMed=27125250;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; S.alboniger pac (PuroR).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0265 ! FRTL-5
SX   Sex unspecified
AG   6W
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
RX   PubMed=15388794; DOI=10.1210/me.2004-0172;
RA   De Vita G., Bauer L., Correa da Costa V.M., De Felice M., Baratta M.G.,
RA   De Menna M., Di Lauro R.;
RT   "Dose-dependent inhibition of thyroid differentiation by RAS
RT   oncogenes.";
RL   Mol. Endocrinol. 19:76-89(2005).
//
RX   PubMed=27125250; DOI=10.1038/srep25268; PMCID=PMC4850481;
RA   Vitiello M., Valentino T., De Menna M., Crescenzi E., Francesca P.,
RA   Rea D., Arra C., Fusco A., De Vita G., Cerchia L., Fedele M.;
RT   "PATZ1 is a target of miR-29b that is induced by Ha-Ras oncogene in
RT   rat thyroid cells.";
RL   Sci. Rep. 6:25268.1-25268.10(2016).
//